{"id":"NCT01209780","sponsor":"Novartis Vaccines","briefTitle":"Safety and Immunogenicity of Trivalent Subunit Inactivated Flu Vaccine Administered to Healthy Children and Adolescents 3 to 17 Years of Age","officialTitle":"A Multi-center, Phase III, Randomized, Observer Blind Study to Evaluate the Safety, Tolerability and Immunogenicity of a Trivalent Subunit Inactivated Flu Vaccine in Healthy Children and Adolescents 3 to 17 Years of Age","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-09","primaryCompletion":"2011-03","completion":"2011-09","firstPosted":"2010-09-27","resultsPosted":"2014-03-11","lastUpdate":"2014-03-11"},"enrollment":3116,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Seasonal Influenza"],"interventions":[{"type":"BIOLOGICAL","name":"TIV","otherNames":[]},{"type":"BIOLOGICAL","name":"TIVf","otherNames":[]},{"type":"BIOLOGICAL","name":"Comparator TIV","otherNames":[]}],"arms":[{"label":"TIV (3-8 years)","type":"EXPERIMENTAL"},{"label":"Control TIV (3-8 years)","type":"ACTIVE_COMPARATOR"},{"label":"TIV ( 9-17 years)","type":"EXPERIMENTAL"},{"label":"Control TIV ( (9-17 years)","type":"ACTIVE_COMPARATOR"}],"summary":"This study will evaluate the safety and immunogenicity in healthy children and adolescents after one or two IM dose(s) of trivalent subunit inactivated flu vaccine.","primaryOutcome":{"measure":"Comparison of Antibody Responses of Investigational TIV to Control Vaccine in Terms of the Percentage of Subjects Achieving Seroconversion","timeFrame":"Day 22 for non-naive/Day 50 for naive subjects","effectByArm":[{"arm":"TIV (3-8 Years)","deltaMin":95,"sd":null},{"arm":"Control (3-8 Years)","deltaMin":94,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"3 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":4,"exclusionCount":12},"locations":{"siteCount":13,"countries":["Colombia","Mexico","Panama","Philippines"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":14,"n":1039},"commonTop":["injection site pain","pyrexia","headache","malaise","myalgia"]}}